Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) hit a new 52-week high during trading on Friday . The company traded as high as $166.2620 and last traded at $166.2620, with a volume of 25 shares trading hands. The stock had previously closed at $163.71.
Merck KGaA Stock Up 0.3%
The firm has a market cap of $21.22 billion, a P/E ratio of 25.07 and a beta of 0.96. The stock’s 50 day simple moving average is $137.83 and its 200 day simple moving average is $141.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
